NASDAQ$COO

The Cooper Companies Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

CooperCompanies reported strong Q3 2023 results, marked by record revenues in both CooperVision and CooperSurgical, driven by strategic growth initiatives.

CooperCompanies announced a 10% increase in revenue to $930.2 million. GAAP diluted EPS was $1.71, while non-GAAP diluted EPS reached $3.35. The company's performance was driven by strong results from both CooperVision and CooperSurgical.

  • Revenue increased by 10% year-over-year to $930.2 million.
  • CooperVision revenue was up 11% to $630.2 million.
  • CooperSurgical revenue increased by 8% to $300.0 million.
  • Non-GAAP diluted EPS increased by 5% to $3.35.

Headline financials

Total Revenue

$930M

Previous: $843M+10.3%
EPS (adj)

$0.84

Previous: $0.80+5.0%
GAAP Gross Margin

66.0%

Previous: 65.0%+1.5%
GAAP Operating Margin

16.0%

Previous: 17.0%-5.9%
Capital Expenditures

-$248M

Previous: -$147M-68.3%
Free Cash Flow

$186M

Previous: $415M-55.2%
Net Income

$85.3M

Previous: $98.4M-13.3%
Operating Income

$152M

Previous: $141M+7.8%
Gross Profit

$610M

Previous: $552M+10.5%
Cash & Equivalents

$117M

Previous: $246M-52.4%
Total Assets

$11.7B

Previous: $11.6B+1.3%

Revenue & EPS history

Cooper · Revenue · Quarterly

$930M

Q3 2023+10.3%vs Q3 2022
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Revenue by segment

Cooper · $300M total across 2 segments · Q3 2023

  • Office and Surgical
    $178M+7.9%
  • Fertility
    $122M+8.9%

Forward guidance

The Company updated its fiscal year 2023 financial guidance. Fiscal 2023 total revenue of $3,578 - $3,595 million (organic growth of 9% to 10%). Fiscal 2023 non-GAAP diluted earnings per share of $12.72 - $12.90.

Tailwinds

  • Fiscal 2023 total revenue of $3,578 - $3,595 million (organic growth of 9% to 10%)
  • CVI revenue of $2,414 - $2,425 million (organic growth of 10% to 11%)
  • CSI revenue of $1,164 - $1,170 million (organic growth of 7% to 8%)
  • Fiscal fourth quarter 2023 total revenue of $912 - $929 million (organic growth of 7% to 9%)
  • CVI revenue of $613 - $624 million (organic growth of 8% to 10%)

Headwinds

  • CSI revenue of $299 - $305 million (organic growth of 5% to 7%)
  • Fiscal fourth quarter 2023 non-GAAP diluted earnings per share of $3.39 - $3.57
  • Non-GAAP diluted earnings per share guidance excludes amortization and impairment of intangible assets
  • Excludes other exceptional or unusual income or gains and charges or expenses including acquisition and integration costs
  • Company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

+0.6%

Avg return

Earnings day

-0.3%

Avg return

5 days after

-0.1%

Avg return

30 days after

52%

36 / 69 earnings

Positive

+12.1%

Q3 2024

Best reaction

-12.8%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026+10.3%+9.7%
Q1 2026-4.6%-8.0%-12.5%
Q4 2025-4.3%+4.8%+5.3%
Q3 2025-12.8%-11.8%-8.9%
Q2 2025+0.0%-0.3%+3.6%
Q1 2025-6.6%-13.1%-18.9%
Q4 2024-6.0%-5.6%-12.6%
Q3 2024+12.1%+12.1%+16.4%
Q2 2024+3.5%+3.8%-4.2%
Q1 2024+8.1%+7.3%+7.4%
Q4 2023-2.2%-0.7%+6.8%
Q3 2023-2.1%-3.5%-15.9%
Q2 2023-4.0%-5.1%+3.2%
Q1 2023+8.7%+3.9%+15.4%
Q4 2022-1.6%+4.8%+9.7%
Q3 2022+4.1%+2.5%-8.5%
Q2 2022-0.3%+1.3%-7.2%
Q1 2022+2.1%-8.5%+3.1%
Q4 2021+4.8%+8.7%+12.2%
Q3 2021+1.1%-0.7%-7.6%
Q2 2021-0.7%-3.2%+6.0%
Q1 2021+1.8%+0.3%+1.1%
Q4 2020+3.3%+3.3%+8.6%
Q3 2020+2.0%+0.3%+5.7%
Q2 2020-0.2%-5.0%-9.1%
Q1 2020-1.3%-0.9%-17.3%
Q4 2019-1.6%-2.4%+3.3%
Q3 2019-3.5%-6.7%-8.3%
Q2 2019+4.5%+9.0%+18.2%
Q1 2019-1.8%+0.1%+1.0%
Q4 2018-11.6%-7.3%-10.4%
Q3 2018-3.7%-3.4%+4.3%
Q2 2018+1.4%-0.4%+6.0%
Q1 2018+2.1%-3.8%-11.5%
Q4 2017-3.2%-1.9%-1.5%
Q3 2017-4.0%-2.5%-3.7%
Q2 2017+8.9%+10.5%+9.4%
Q1 2017-3.1%-3.6%-0.4%
Q4 2016+1.3%+4.1%+5.2%
Q3 2016+0.0%+1.3%-3.6%
Q2 2016-0.1%-0.4%+7.1%
Q1 2016+6.4%
Q4 2015-12.8%
Q3 2015-7.1%
Q2 2015-5.1%
Q1 2015+9.7%
Q4 2014-4.4%
Q3 2014+0.7%
Q2 2014+1.7%
Q1 2014+4.3%
Q4 2013-4.6%
Q3 2013-1.8%
Q2 2013+8.1%
Q1 2013+2.5%
Q4 2012+1.0%
Q3 2012+10.3%
Q2 2012-4.1%
Q1 2012+2.8%
Q4 2008+2.8%
Q4 2011+2.8%
Q3 2011-1.8%
Q2 2011+1.4%
Q2 2010+1.4%
Q1 2010+8.9%
Q1 2011+1.0%
Q4 2010-1.5%
Q3 2010+5.8%
Q4 2009+5.8%
Q3 2009+5.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro